Category Archives: European Union
The EMA and Foreign Data_Part 2
Previously we looked at data from the European Medicines Agency, which showed the increasing role since 2005 that some ‘Rest of the World’ nations were playing in enrolling patients in clinical trials supplying pivotal data for marketing authorisation applications (MAAs) … Continue reading
Posted in EMA, European Union, Regulations
Leave a comment
The EMA and Foreign Data_Part 1
In recent years we have seen an increase in the number of trials conducted for EU marketing authority applications (MAA) in areas other than what was considered to be in the two main European [European Union (EU) / European Economic … Continue reading
Posted in EMA, European Union, Regulations
Leave a comment
Brexit and Clinical Trials_Part 2
What are the implications and consequences of the Brexit vote for the pharmaceutical and MedTech industries so close to the heart of most reading this piece? Many in these industries and in academic research establishments argued that a Brexit vote … Continue reading
Posted in European Union
Leave a comment
Brexit and Clinical Trials_Part 1
Well, the people of Britain have now spoken – albeit not that clearly given a 51.9%:48.1% split in the referendum voting figures. Nevertheless, it’s a democratic decision and now the word on almost everyone’s lips is “Brexit”. Despite a protest … Continue reading
Posted in European Union, Uncategorized
Leave a comment
New EU Trial Regulations – Time Will Tell……
All those engaged in trials within Europe should be familiar – at least to some degree if not intimately – with the ‘Clinical Trials Directive’ (or to give it its full, and understandably seldom used, full document title: ‘Directive 2001/20/EC … Continue reading
Posted in EMA, European Union, Regulations
Leave a comment
New EMA policy on access to clinical trial data – still a hot topic
Transparency of data is paramount to scientific communities worldwide and a sine qua non for the unbiased technological advancement. This, naturally, also refers to scientific research in medicine. As we read on through the European Medicines Agency’s (EMA) mission and responsibilities, … Continue reading
Posted in EMA, European Union, Regulations
Leave a comment
Get ready for ESC 2014 – the Europe’s greatest cardiology event
At Clinical Accelerator, we are getting excited about the European Society of Cardiology conference, which is to be held in Barcelona next week and has the theme “innovation and the heart”. The excitement focuses on the late-breaking trial results of … Continue reading
Posted in Clinical Accelerator, Conferences, European Union
Leave a comment
NHS: declining UK position on the clinical trial stage
The “choice destination” of clinical trials evolves hugely as economics of competing countries fluctuate and political decisions introduce new obstructions. The popularity of the UK, for instance, fell steeply in the 21st century, which epitomises some of the acting forces. … Continue reading
Posted in European Union
1 Comment
clinicalaccelerator.com 
You must be logged in to post a comment.